Titre : Hémoglobinurie

Hémoglobinurie : Questions médicales fréquentes

Termes MeSH sélectionnés :

Attention Deficit Disorder with Hyperactivity
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Hémoglobinurie : Questions médicales les plus fréquentes", "headline": "Hémoglobinurie : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Hémoglobinurie : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-02-28", "dateModified": "2025-02-22", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Hémoglobinurie" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Protéinurie", "url": "https://questionsmedicales.fr/mesh/D011507", "about": { "@type": "MedicalCondition", "name": "Protéinurie", "code": { "@type": "MedicalCode", "code": "D011507", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C23.888.942.750" } } }, "about": { "@type": "MedicalCondition", "name": "Hémoglobinurie", "alternateName": "Hemoglobinuria", "code": { "@type": "MedicalCode", "code": "D006456", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Hubert Schrezenmeier", "url": "https://questionsmedicales.fr/author/Hubert%20Schrezenmeier", "affiliation": { "@type": "Organization", "name": "Institute of Transfusion Medicine, University of Ulm, Ulm, Germany." } }, { "@type": "Person", "name": "Austin G Kulasekararaj", "url": "https://questionsmedicales.fr/author/Austin%20G%20Kulasekararaj", "affiliation": { "@type": "Organization", "name": "From the Hematology and Transplant Unit, French Reference Center for Aplastic Anemia and Paroxysmal Nocturnal Hemoglobinuria, Saint-Louis Hospital (R.P.L., F.S.F.), and Université de Paris (R.P.L.), Paris, Centre Hospitalier Universitaire (CHU) de Toulouse, Institut Universitaire du Cancer de Toulouse-Oncopole, Toulouse (S.T.), and CHU Lille, Université de Lille, Lille (L.T.) - all in France; the Department of Hematology and Stem Cell Transplantation, West German Cancer Center, University Hospital Essen, University Duisburg-Essen, Essen (A.R., F.A.), the Department of Hematology, Oncology, Hemostaseology, and Stem Cell Transplantation, University Hospital RWTH Aachen, and the Center for Integrated Oncology Aachen Bonn Cologne Düsseldorf, Aachen (J.P.), the University of Ulm, the Institute of Transfusion Medicine and Immunogenetics, German Red Cross Blood Transfusion Service Baden-Württemberg-Hessen, and University Hospital Ulm, Ulm (H.S., B. Höchsmann), the Department of Oncology, Hematology, and Bone Marrow Transplantation, Section of Pneumology, University Medical Center Hamburg-Eppendorf, Hamburg (P. Schafhausen), and Elblandklinikum Riesa, Riesa (J.S.) - all in Germany; King's College Hospital NHS Foundation Trust (A.G.K., S.G., R.T.), the National Institute for Health and Care Research and Wellcome King's Clinical Research Facility (A.G.K.), King's College London (A.G.K.), and Novartis Pharmaceuticals (C.T.), London, and St. James's University Hospital, Leeds (M.G., R.J.K.) - all in the United Kingdom; Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, and Peking Union Medical College, Beijing (B. Han, C.Y.), the Department of Hematology, Tianjin Medical University General Hospital (R.F., H.L.), and the Department of Hematology, Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences (L.Z.), Tianjin, and China Novartis Institutes for BioMedical Research, Shanghai (Z.W., S.L.) - all in China; the Division of Hematology, Hospital A Beneficência Portuguesa, São Paulo (P. Scheinberg), and ABC Medical School, Santo André (V.A.Q.M.) - both in Brazil; the Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland (J.P.M.); Osaka University Graduate School of Medicine, Suita (Y.U.), Kyoto University Hospital, Kyoto (T.K.), and Japanese Red Cross Society Suwa Hospital, Suwa (M.U.) - all in Japan; Duke University School of Medicine and Duke Cancer Institute, Durham, NC (C.M.C.); Unità Operativa Complessa Oncoematologia, AULSS7 Pedemontana, Bassano del Grappa (E.D.B.), Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan (W.B.), Division of Hematology, University of Turin, Città della Salute e della Scienza, Turin (E.B.), Instituto per lo Studio, la Prevenzione e la Rete Oncologica, and Azienda Ospedaliero-Universitaria Careggi, Florence (R.N.), AORN Moscati, Avellino (L.M., A.M.R.), and University of Naples Federico II, Naples (A.M.R.) - all in Italy; Radboud University Medical Center, Nijmegen, the Netherlands (S.M.C.L.); the Hematology Unit, Department of Medicine, Hospital Umum Sarawak, Kuching (L.P.C.), and the Hematology Unit, Queen Elizabeth Hospital, Kota Kinabalu (L.W.L.L.) - both in Malaysia; Hospital Clinic of Barcelona (A.G.) and the Severe Aplastic Anemia Working Party of the European Society for Blood and Marrow Transplantation (R.P.L., A.G.K., M.G., W.B., S.T., L.T., F.S.F., L.M., A.M.R.) - both in Barcelona; the Department of Hematology and Oncology and the Department of Clinical Pathology, Hualien Tzu Chi Hospital, the Buddhist Tzu Chi Medical Foundation, and the Institute of Medical Sciences, Tzu Chi University, Hualien, Taiwan (W.-H.H.); the Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea (J.H.J.); Medical College of Georgia, Augusta (A.K.); City of Hope Medical Center, Duarte, CA (V.P.); the Department of Laboratory Medicine, National University Hospital, Singapore (E.-S.Y.); Novartis Pharma (C.K., R.L., M.D.) and Novartis BioMedical Research (A.V.) - both in Basel, Switzerland; and Novartis Healthcare Private, Hyderabad, India (P.B., R.K., S.M.)." } }, { "@type": "Person", "name": "Robert A Brodsky", "url": "https://questionsmedicales.fr/author/Robert%20A%20Brodsky", "affiliation": { "@type": "Organization", "name": "Division of Hematology, Department of Medicine, School of Medicine, Johns Hopkins University, Baltimore, MD." } }, { "@type": "Person", "name": "Jun-Ichi Nishimura", "url": "https://questionsmedicales.fr/author/Jun-Ichi%20Nishimura", "affiliation": { "@type": "Organization", "name": "Osaka University Graduate School of Medicine, Department of Hematology and Oncology." } }, { "@type": "Person", "name": "Britta Höchsmann", "url": "https://questionsmedicales.fr/author/Britta%20H%C3%B6chsmann", "affiliation": { "@type": "Organization", "name": "Institute of Transfusion Medicine, University of Ulm, Ulm, Germany." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Identification of attention deficit hyperactivity disorder with deep learning model.", "datePublished": "2023-05-16", "url": "https://questionsmedicales.fr/article/37191853", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1007/s13246-023-01275-y" } }, { "@type": "ScholarlyArticle", "name": "Methylphenidate for children and adolescents with attention deficit hyperactivity disorder (ADHD).", "datePublished": "2023-03-27", "url": "https://questionsmedicales.fr/article/36971690", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1002/14651858.CD009885.pub3" } }, { "@type": "ScholarlyArticle", "name": "Altered somatosensory processing in adult attention deficit hyperactivity disorder.", "datePublished": "2024-08-13", "url": "https://questionsmedicales.fr/article/39138461", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1186/s12888-024-06002-9" } }, { "@type": "ScholarlyArticle", "name": "Parental perspectives on attention-deficit/hyperactivity disorder treatments for children.", "datePublished": "2022-06-13", "url": "https://questionsmedicales.fr/article/35695509", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1177/13591045221108836" } }, { "@type": "ScholarlyArticle", "name": "Potential Inflammatory Biomarker in Patients with Attention Deficit Hyperactivity Disorder.", "datePublished": "2022-10-27", "url": "https://questionsmedicales.fr/article/36361835", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.3390/ijms232113054" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "États, signes et symptômes pathologiques", "item": "https://questionsmedicales.fr/mesh/D013568" }, { "@type": "ListItem", "position": 3, "name": "Signes et symptômes", "item": "https://questionsmedicales.fr/mesh/D012816" }, { "@type": "ListItem", "position": 4, "name": "Manifestations urologiques", "item": "https://questionsmedicales.fr/mesh/D020924" }, { "@type": "ListItem", "position": 5, "name": "Protéinurie", "item": "https://questionsmedicales.fr/mesh/D011507" }, { "@type": "ListItem", "position": 6, "name": "Hémoglobinurie", "item": "https://questionsmedicales.fr/mesh/D006456" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Hémoglobinurie - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Hémoglobinurie", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-04", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Hémoglobinurie", "description": "Comment diagnostiquer l'hémoglobinurie ?\nQuels tests sont utilisés pour confirmer l'hémoglobinurie ?\nQuels signes indiquent une hémoglobinurie ?\nL'hémoglobinurie est-elle visible à l'œil nu ?\nQuels autres tests peuvent être nécessaires ?", "url": "https://questionsmedicales.fr/mesh/D006456?mesh_terms=Attention+Deficit+Disorder+with+Hyperactivity&page=3#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Hémoglobinurie", "description": "Quels sont les symptômes de l'hémoglobinurie ?\nL'hémoglobinurie cause-t-elle des douleurs ?\nPeut-on avoir de la fièvre avec l'hémoglobinurie ?\nL'hémoglobinurie entraîne-t-elle une anémie ?\nY a-t-il des signes urinaires associés ?", "url": "https://questionsmedicales.fr/mesh/D006456?mesh_terms=Attention+Deficit+Disorder+with+Hyperactivity&page=3#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Hémoglobinurie", "description": "Comment prévenir l'hémoglobinurie ?\nLes infections urinaires peuvent-elles être évitées ?\nY a-t-il des mesures spécifiques pour les athlètes ?\nLes maladies héréditaires peuvent-elles être évitées ?\nL'alimentation joue-t-elle un rôle ?", "url": "https://questionsmedicales.fr/mesh/D006456?mesh_terms=Attention+Deficit+Disorder+with+Hyperactivity&page=3#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Hémoglobinurie", "description": "Comment traiter l'hémoglobinurie ?\nLes transfusions sont-elles nécessaires ?\nDes médicaments peuvent-ils aider ?\nL'hydratation est-elle importante ?\nQuand consulter un médecin pour l'hémoglobinurie ?", "url": "https://questionsmedicales.fr/mesh/D006456?mesh_terms=Attention+Deficit+Disorder+with+Hyperactivity&page=3#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Hémoglobinurie", "description": "Quelles complications peuvent survenir ?\nL'hémoglobinurie peut-elle endommager les reins ?\nY a-t-il un risque d'infection ?\nDes problèmes cardiovasculaires peuvent-ils survenir ?\nL'hémoglobinurie peut-elle être fatale ?", "url": "https://questionsmedicales.fr/mesh/D006456?mesh_terms=Attention+Deficit+Disorder+with+Hyperactivity&page=3#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Hémoglobinurie", "description": "Quels sont les facteurs de risque de l'hémoglobinurie ?\nLes athlètes sont-ils plus à risque ?\nLes maladies génétiques augmentent-elles le risque ?\nCertains médicaments sont-ils des facteurs de risque ?\nL'âge influence-t-il le risque d'hémoglobinurie ?", "url": "https://questionsmedicales.fr/mesh/D006456?mesh_terms=Attention+Deficit+Disorder+with+Hyperactivity&page=3#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment diagnostiquer l'hémoglobinurie ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Un test urinaire détecte l'hémoglobine libre, souvent accompagné d'analyses sanguines." } }, { "@type": "Question", "name": "Quels tests sont utilisés pour confirmer l'hémoglobinurie ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Des tests de laboratoire comme l'analyse d'urine et la numération des globules rouges sont utilisés." } }, { "@type": "Question", "name": "Quels signes indiquent une hémoglobinurie ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Une urine de couleur rouge ou brune, associée à des douleurs abdominales, peut indiquer l'hémoglobinurie." } }, { "@type": "Question", "name": "L'hémoglobinurie est-elle visible à l'œil nu ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Oui, l'urine peut apparaître rougeâtre ou brunâtre, mais des tests sont nécessaires pour confirmation." } }, { "@type": "Question", "name": "Quels autres tests peuvent être nécessaires ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Des tests pour évaluer la fonction rénale et rechercher des infections peuvent être requis." } }, { "@type": "Question", "name": "Quels sont les symptômes de l'hémoglobinurie ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes incluent urine colorée, douleurs abdominales et fatigue, selon la cause." } }, { "@type": "Question", "name": "L'hémoglobinurie cause-t-elle des douleurs ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des douleurs abdominales ou lombaires peuvent accompagner l'hémoglobinurie." } }, { "@type": "Question", "name": "Peut-on avoir de la fièvre avec l'hémoglobinurie ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Oui, une fièvre peut survenir si l'hémoglobinurie est causée par une infection sous-jacente." } }, { "@type": "Question", "name": "L'hémoglobinurie entraîne-t-elle une anémie ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Oui, la destruction des globules rouges peut provoquer une anémie, entraînant fatigue et faiblesse." } }, { "@type": "Question", "name": "Y a-t-il des signes urinaires associés ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Des signes comme des mictions fréquentes ou douloureuses peuvent être présents avec l'hémoglobinurie." } }, { "@type": "Question", "name": "Comment prévenir l'hémoglobinurie ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Évitez les traumatismes, les infections et maintenez une bonne hydratation pour prévenir l'hémoglobinurie." } }, { "@type": "Question", "name": "Les infections urinaires peuvent-elles être évitées ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Oui, une bonne hygiène et une hydratation adéquate aident à prévenir les infections urinaires." } }, { "@type": "Question", "name": "Y a-t-il des mesures spécifiques pour les athlètes ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Les athlètes doivent éviter les blessures et bien s'hydrater pour prévenir l'hémoglobinurie." } }, { "@type": "Question", "name": "Les maladies héréditaires peuvent-elles être évitées ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Non, mais un suivi médical régulier peut aider à gérer les risques associés aux maladies héréditaires." } }, { "@type": "Question", "name": "L'alimentation joue-t-elle un rôle ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Une alimentation équilibrée peut renforcer le système immunitaire et réduire les risques d'infections." } }, { "@type": "Question", "name": "Comment traiter l'hémoglobinurie ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Le traitement dépend de la cause sous-jacente, incluant transfusions ou médicaments." } }, { "@type": "Question", "name": "Les transfusions sont-elles nécessaires ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Des transfusions peuvent être nécessaires si l'hémoglobinurie cause une anémie sévère." } }, { "@type": "Question", "name": "Des médicaments peuvent-ils aider ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des médicaments pour traiter l'infection ou la maladie sous-jacente peuvent être prescrits." } }, { "@type": "Question", "name": "L'hydratation est-elle importante ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Oui, une bonne hydratation aide à diluer l'urine et à réduire les symptômes de l'hémoglobinurie." } }, { "@type": "Question", "name": "Quand consulter un médecin pour l'hémoglobinurie ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Consultez un médecin si vous avez une urine colorée ou des symptômes associés persistants." } }, { "@type": "Question", "name": "Quelles complications peuvent survenir ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Des complications incluent l'anémie sévère, des lésions rénales et des infections urinaires." } }, { "@type": "Question", "name": "L'hémoglobinurie peut-elle endommager les reins ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Oui, une hémoglobinurie prolongée peut entraîner des lésions rénales et une insuffisance rénale." } }, { "@type": "Question", "name": "Y a-t-il un risque d'infection ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Oui, l'hémoglobinurie peut augmenter le risque d'infections urinaires et rénales." } }, { "@type": "Question", "name": "Des problèmes cardiovasculaires peuvent-ils survenir ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Oui, une anémie sévère due à l'hémoglobinurie peut entraîner des problèmes cardiovasculaires." } }, { "@type": "Question", "name": "L'hémoglobinurie peut-elle être fatale ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Dans de rares cas, des complications graves peuvent survenir, rendant la situation potentiellement fatale." } }, { "@type": "Question", "name": "Quels sont les facteurs de risque de l'hémoglobinurie ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Les traumatismes, infections, maladies héréditaires et certains médicaments augmentent le risque." } }, { "@type": "Question", "name": "Les athlètes sont-ils plus à risque ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les athlètes peuvent être à risque en raison de traumatismes répétés et de déshydratation." } }, { "@type": "Question", "name": "Les maladies génétiques augmentent-elles le risque ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des maladies comme la drépanocytose augmentent le risque d'hémoglobinurie." } }, { "@type": "Question", "name": "Certains médicaments sont-ils des facteurs de risque ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Oui, certains médicaments comme les antibiotiques peuvent provoquer une hémoglobinurie." } }, { "@type": "Question", "name": "L'âge influence-t-il le risque d'hémoglobinurie ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les personnes âgées peuvent être plus à risque en raison de maladies sous-jacentes." } } ] } ] }

Sources (10000 au total)

Methylphenidate for children and adolescents with attention deficit hyperactivity disorder (ADHD).

Attention deficit hyperactivity disorder (ADHD) is one of the most commonly diagnosed and treated psychiatric disorders in childhood. Typically, children and adolescents with ADHD find it difficult to... To assess the beneficial and harmful effects of methylphenidate for children and adolescents with ADHD.... We searched CENTRAL, MEDLINE, Embase, three other databases and two trials registers up to March 2022. In addition, we checked reference lists and requested published and unpublished data from manufac... We included all randomised clinical trials (RCTs) comparing methylphenidate versus placebo or no intervention in children and adolescents aged 18 years and younger with a diagnosis of ADHD. The search... Two review authors independently conducted data extraction and risk of bias assessment for each trial. Six review authors including two review authors from the original publication participated in the... We included 212 trials (16,302 participants randomised); 55 parallel-group trials (8104 participants randomised), and 156 cross-over trials (8033 participants randomised) as well as one trial with a p... methylphenidate versus placebo or no intervention may improve teacher-rated ADHD symptoms (standardised mean difference (SMD) -0.74, 95% confidence interval (CI) -0.88 to -0.61; I² = 38%; 21 trials; 1... methylphenidate may cause more adverse events considered non-serious versus placebo or no intervention (RR 1.23, 95% CI 1.11 to 1.37; I² = 72%; 35 trials 5342 participants; very low-certainty evidence... The majority of our conclusions from the 2015 version of this review still apply. Our updated meta-analyses suggest that methylphenidate versus placebo or no-intervention may improve teacher-rated ADH...

Altered somatosensory processing in adult attention deficit hyperactivity disorder.

Tactile sensitivity and sensory overload in ADHD are well-documented in clinical-, self-, and parent- reports, but empirical evidence is scarce and ambiguous and focuses primarily on children. Here, w... Somatosensory evoked potential (SEP) amplitudes were measured in 27 adults with ADHD and 24 controls during four conditions (rest, stroking of the own arm, stroking of the arm by a researcher, and str... Participants with ADHD self-reported greater tactile sensitivity and ADHD symptom severity than controls and received higher scores on the Qb-test. These values correlated with one another. ADHD parti... We find that ADHD symptomatology and touch sensitivity are directly linked, using both self-reports and experimental measures. We also find evidence of tactile sensory overload in ADHD, and an indicat...

Sensory Processing in Children and Adolescents with Attention Deficit Hyperactivity Disorder.

The aim is to assess the sensory processing difficulties in children and adolescents with ADHD.... In all, 38 ADHD children of the age group 6-14 years and 34 age- and gender-matched typically developing controls were included in the study. Sensory processing was assessed on Child Sensory Profile-2... A significantly higher sensory processing difficulties were seen in children with ADHD than typically developing controls. There were positive correlations between the scores of Child sensory profile ... Sensory problems were common in children with ADHD and add to the functional impairments....

Preterm postnatal complications and risk of attention-deficit/hyperactivity disorder.

To investigate the association between the risk of attention-deficit/hyperactivity disorder (ADHD) and preterm birth and determine how postnatal complications in children born preterm is associated wi... This population-based cohort study used data from the Hong Kong electronic medical records. We followed 359 614 children (48% female; 6-17 years old, mean 11 years 7 months, SD 3 years 2 months) born ... The risk of ADHD was 4.0% in children born at term and 5.1% in children born preterm. The odds ratio for ADHD was 2.08 (95% confidence interval [CI] 1.64-2.64) for children born extremely preterm, 1.6... Children born preterm in all subcategories, from extremely preterm to late preterm, have increased risk of ADHD. Early respiratory infection partially mediates the risk of ADHD in children born preter...